London Quantum Group

What London Quantum Group does

London Quantum Group Limited is a London-based, privately held healthcare technology company operating a single product, Provenance, in the UK NHS primary care market. The company was incorporated recently — its website copyright reads 2026 — and operates with 1–10 employees, no disclosed funding rounds, and no institutional investors, consistent with a founder-led, bootstrapped early-stage entity.

Provenance is a privacy-first clinical research access platform built for NHS GP practices. The platform enables practices to identify patients eligible for clinical trials using existing practice records, route those identifications through a practice-controlled approval workflow, and connect approved patients to trusted research networks and at-scale delivery sites. The core technical claim is a zero-data-access encryption architecture that structurally prevents London Quantum Group from viewing practice data — described as a 'structural guarantee' rather than a privacy promise — with explicit alignment to ICO and ISO standards and to NHS Information Governance requirements. No data leaves the practice system, and no new clinical workflows are imposed.

Commercially, the company pursues an enterprise direct-sales motion targeting individual NHS GP practices via a 'Request a demo' CTA on its website, implying quote-based, negotiated enterprise pricing under a recurring subscription model. Revenue mechanics are not publicly disclosed, no customers are named, and no management team, partnerships, or certifications are listed in available sources. The company explicitly frames its mission around building safety into innovation across healthcare, with forward-looking language suggesting intent to expand beyond its current vertical.

Name

London Quantum Group

Legal name

London Quantum Group Limited

Website

https://londonquantumgroup.com

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

London Quantum Group is a London-based, privately held health-tech company building Provenance, a privacy-first platform that enables NHS GP practices to identify and enrol eligible patients in clinical trials without sharing or extracting patient data.

Ownership category

akta.pro rank

Product category

Clinical Research Technology

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Quantum Cloud Security, Identity & Compliance (HDAGAIAF)

akta.pro secondary industries

Quantum-Safe Data-at-Rest Protection (Storage/Database/File Encryption) (HDAGAGAI), Quantum-Safe Secure Messaging & Data-in-Transit Protection (HDAGAGAH), Quantum Standards, Compliance & Policy Advisory (HDAGALAK)

Keywords

• Clinical trial platform
• Healthcare data privacy
• Patient recruitment software
• Primary care research
• Medical research infrastructure

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Clinical Research Platform Subscription: Based on the B2B SaaS nature of the product targeting GP practices with a 'Request a demo' sales motion, Provenance likely operates on a subscription model where NHS practices or CCGs pay recurring fees for access to the clinical research platform. The platform generates research revenue for practices alongside existing care work.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

London Quantum Group develops Provenance, a B2B SaaS platform that enables NHS GP practices to identify patients eligible for clinical trials from existing records and connect those approved patients to active trial networks. The platform uses privacy-first encryption-based infrastructure so that no patient data leaves the practice system and the vendor cannot access it, aligning with NHS Information Governance, ICO, and ISO standards, and requires no workflow changes for the practice.

Product overview

London Quantum Group offers a single unified product called Provenance — a clinical research access platform designed specifically for primary care. Provenance enables GP practices to identify patients matching study criteria, review and approve outreach, and connect approved patients to research networks and delivery sites, all without data leaving the practice system.

Differentiator

Problem solved

Functional benefit

Brands

• Provenance: Clinical research access platform for primary care practices, enabling GP practices to identify eligible patients and connect them to active trials with privacy-first infrastructure.

Products and services

• Provenance Provenance is a clinical research access platform for NHS GP practices that identifies patients matching clinical trial criteria from existing practice records, routes every outreach through practice-controlled approval, and connects approved patients to trusted research networks and at-scale trial delivery sites. It is built on privacy-first encryption infrastructure that ensures no patient data leaves the practice system and that the vendor cannot access the data, aligning with NHS Information Governance, ICO, and ISO standards.

Quantifiable outcome

• Bring high-quality clinical research opportunities to patients without changing how GP practices work or sharing their data

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Regional players

• EMIS Group: Major supplier of clinical software to UK GP practices, including EMIS Web. Comparable as a UK primary-care technology vendor and a natural integration or channel partner for Provenance.
• TPP: UK provider of the SystmOne GP clinical system used widely across NHS primary care. Comparable as an incumbent UK primary-care platform that Provenance must interoperate with or risk being displaced by.

Direct peers

• TriNetX: Global health research network enabling feasibility and patient-finding across provider organisations for clinical trials. Comparable to Provenance's network-and-matching model, though at a larger institutional scale.
• Owkin: Federated-learning and privacy-preserving AI platform for healthcare that keeps patient data at the source institution. Highly comparable to London Quantum Group's structural-privacy approach applied to clinical research enablement.
• AutoCruitment: Digital patient recruitment platform for clinical trials combining outreach, pre-screening, and site referral. Comparable as a B2B clinical-trial-recruitment vendor targeting enrolment throughput.
• Mendel: AI platform for clinical trial patient matching and cohort discovery using structured and unstructured EMR data. Comparable in target use case (trial recruitment) and customer base (providers and sponsors).
• Deep 6 AI: AI-powered platform that mines electronic medical records to match patients to clinical trials. Directly comparable to Provenance's eligibility-identification workflow applied to investigator and sponsor trials.

Broad incumbents

• Medidata (Dassault Systèmes): Major clinical trial technology platform covering EDC, eCOA, and trial operations. Overlaps with Provenance on the sponsor-facing trial enablement workflow but as part of a much broader portfolio.
• IQVIA: Global clinical research services and technology incumbent covering trial design, site management, and real-world evidence. Operates broadly in the same clinical-research enablement space where Provenance competes.

Emerging players

• Duality Technologies: Privacy-preserving computation (homomorphic encryption, secure multiparty computation) vendor serving regulated industries including healthcare. Comparable on the underlying cryptographic-privacy technology layer that Provenance depends on.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/londonquantumgroup

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about London Quantum Group